Global Canine Weight Loss Drugs Market By Type (Slentrol (Dirlotapide), Orlistat (Xenical), Lorcaserin (Belviq)), By Application (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-Commerce), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2030

Canine Weight Loss Drugs Market Overview:

The Global Canine Weight Loss Drugs Market size was valued at USD 698.5 million in 2021 and is projected to reach USD 1.2 billion by 2030, growing at a CAGR of 6.9% from 2022 to 2030.

The report on Canine Weight Loss Drugs Market offers an in-depth analysis of market trends, drivers, restraints, opportunities, etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global canine weight loss drugs Market is segmented on the basis of type, application, and geography.

Canine Weight Loss Drugs Market Scope:

By type, the market is segmented into Slentrol (Dirlotapide), Orlistat (Xenical), Lorcaserin (Belviq), Naltrexone HCl, and bupropion (Contrave), Liraglutide (Saxenda), Phentermine, and Phentermine and Topiramate (Qsymia). By application, the market is divided into Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-Commerce.

Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Major players profiled in the report include Pfizer Animal Health, GlaxoSmithKline plc., Arena Pharmaceuticals Inc., Takeda Pharmaceuticals U.S.A., Novo Nordisk A/S, Cigna, and Others.

Key Market Segments

Type

• Slentrol (Dirlotapide)
• Orlistat (Xenical)
• Lorcaserin (Belviq)
• Naltrexone HCl and bupropion (Contrave)
• Liraglutide (Saxenda)
• Phentermine
• Phentermine and Topiramate (Qsymia)

Application

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• E-Commerce

Canine Weight Loss Drugs Market Drivers:

There are several factors driving the growth of the Canine Weight Loss Drugs Market. Firstly, the increasing prevalence of obesity in dogs is leading to higher demand for weight loss drugs. Secondly, advances in veterinary medicine and increasing awareness about pet health have led to a higher number of pet owners seeking medical intervention for their pets’ weight management.

Additionally, the rise in disposable income and growing pet humanization trend have increased the spending capacity of pet owners on veterinary services, including weight loss drugs. The increasing popularity of pet insurance and the availability of financial aid for veterinary services are also contributing to the growth of the market. Finally, the presence of a large number of players in the market, offering a wide range of weight loss drugs, is also fueling the growth of the Canine Weight Loss Drugs Market.

Canine Weight Loss Drugs Market Restraints:

Despite the growth potential of the Canine Weight Loss Drugs Market, there are several factors that could act as restraints. Firstly, the high cost of weight loss drugs can act as a barrier for pet owners who are cost-conscious. Secondly, a lack of awareness and understanding about the availability of weight loss drugs, particularly in rural and underdeveloped regions, can lead to lower demand.

Additionally, the limited availability of veterinary professionals and clinics in certain regions can also limit access to weight-loss drugs. Furthermore, the side effects associated with certain weight loss drugs can also act as a deterrent for pet owners. Finally, the lack of standardization and regulation in the market can also lead to the availability of counterfeit or low-quality drugs, which can harm pets and negatively impact the market.

Key Market Players included in the report:

• Pfizer Animal Health
• GlaxoSmithKline plc.
• Arena Pharmaceuticals Inc.
• Takeda Pharmaceuticals U.S.A.
• Novo Nordisk A/S
• Cigna
• Others

---

Reasons to Get this Report:

In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Canine Weight Loss Drugs Market share analysis of high players, along with company profiles, which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Canine Weight Loss Drugs Market; high-growth regions; and market drivers, restraints, and also market chances.

The analysis covers Canine Weight Loss Drugs Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Canine Weight Loss Drugs Market across sections such as also applications and representatives.

Additionally, the analysis also has a comprehensive review of the crucial players in the Canine Weight Loss Drugs Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

---

The analysis objectives of the report are:

• To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
• To know the Canine Weight Loss Drugs Market by pinpointing its many subsegments.
• To profile the important players and analyze their growth plans.
• To endeavor the amount and value of Canine Weight Loss Drugs Market sub-markets, depending on key regions (various vital states).
• To analyze the Canine Weight Loss Drugs Market concerning growth trends, prospects, and also their participation in the entire sector.
• To examine and study the Canine Weight Loss Drugs Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2012 to 2018, and also prediction to 2028.
• Primary worldwide Canine Weight Loss Drugs Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis, and development plans for next coming years.
• To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

---

For the Canine Weight Loss Drugs Market research study, the following years have been considered to estimate the market size: